In this respect, C1orf64 log2 median expression values were analyzed to assess a differential expression of C1orf64 for histology type, tumor grade, ER status, ErbB2 status, triple negative (TN) status, and outcome across twenty-two breast cancer datasets. This evidence concerns the gene SRARP and breast cancer.